Research service offering qRT-PCR-based gene expression profiling of defense-related genes (CYP, LYK4, CERK1, Beta-1,3-glucanase, Class III endo-chitinase) in apple cultivars to identify resistance to Marssonina apple leaf blotch (MLB), supporting genome-editing breeding programs for resistant cultivars.
This research offering provides molecular diagnostic services to identify apple cultivars with genetic resistance to Diplocarpon coronariae, the fungal pathogen causing Marssonina apple leaf blotch (MLB). MLB is a devastating disease that causes premature defoliation and fruit infection, heavily impacting organic apple production in the eastern United States, particularly affecting popular cultivars like Honeycrisp. By profiling the expression of key defense-related genes—including CYP, LYK4, CERK1, Beta-1,3-glucanase, and Class III endo-chitinase—this service enables apple breeders and genomics researchers to screen germplasm for resistance traits suitable for genome-editing and conventional breeding programs.
Target defense genes and pathways:
Validated methodology:
Applications:
This research is at Technology Readiness Level 4–5 (validated in laboratory and controlled environment). The team has established pathogenicity testing protocols, validated inoculation methods, and identified candidate defense genes. The proposed one-year study will optimize gene primers for qRT-PCR and conduct comprehensive expression profiling to confirm the role of these genes in MLB resistance. Funding is sought to support a Postdoctoral Associate to execute the validation work. The service is positioned to support immediate breeding and research collaborations with apple industry stakeholders, genomics companies, and academic breeding programs seeking molecular markers for MLB resistance.
Virginia Polytechnic Institute and State University (Virginia Tech) is a comprehensive public land‑grant research university with broad graduate and professional programs and a strong industry orientation. An adjacent research and technology park links companies with faculty, shared labs, and prototyping resources, while facilities in the National Capital Region create a direct connection to federal partners and supply‑chain collaborators. Integration with a regional health system supports clinical research and translational pathways, and the statewide extension network enables field deployment and validation with industry and communities. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, and the Department of Defense. A dedicated technology transfer office provides IP management, licensing, startup formation, and industry contracting support.